Skip to content

Igor D. Bandeira

2 papers in the library · 11 citations · publishing 2025

Papers

Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial

Trends in Psychiatry and Psychotherapy May 27, 2025 Mariana V. F. Echegaray, Rodrigo P. Mello, Guilherme M. Magnavita et al. 11 citations

Among people with treatment-resistant depression, the intensity of dissociation caused by a single infusion of ketamine or esketamine is linked to greater antidepressant effect one day later, but only when dissociative symptoms are mild to moderate. For every one-point increase on a dissociation scale up to 15 points, depression scores improved by an average of 0.5 points after 24 hours. This relationship was not observed at 72 hours or 7 days after infusion. The study was not originally designed to test this relationship, so confounding factors were not controlled, and the finding should be considered suggestive rather than definitive.

Repurposed Drugs of Abuse (Stimulants, Ketamine, and Psychedelics): Focus on Risks

Bipolar Disorder January 1, 2025 Breno Souza-Marques, Ana Teresa Caliman-Fontes, Gustavo C. Leal et al.

Some people with bipolar disorder continue to have symptoms despite available treatments, leading researchers to explore repurposing drugs of abuse—such as stimulants, ketamine, and psychedelics—as novel therapies. While clinical trials show promising efficacy for some of these drugs, concerns about their risks have emerged. This chapter examines the potential benefits and, especially, the associated risks, including addiction, worsening of psychiatric symptoms, and adverse physical and cognitive effects. It offers a balanced risk–benefit analysis that weighs these factors against the severity of bipolar disorder, alternative treatments, and the possibility of individualized risk stratification, aiming to inform clinical decisions and guide future research.